Navigation Links
Alzheimer's Association Applauds Social Security Administration for Adding Early-Onset Alzheimer's to Its Compassionate Allowances Initiative

Alzheimer's Association Statement

WASHINGTON, Feb. 11 /PRNewswire-USNewswire/ -- In its effort to improve and expedite the disability determination process, the Social Security Administration (SSA) has announced that it will add early-onset Alzheimer's disease to its Compassionate Allowances Initiative. The initiative identifies debilitating diseases and medical conditions that meet the SSA's disability standards for Social Security Disability Income (SSDI) or Supplemental Security Income (SSI). Inclusion in the initiative allows for faster payment of Social Security benefits to individuals with Alzheimer's disease.  The Alzheimer's Association applauds Social Security Commissioner Michael Astrue and the SSA for understanding that the cognitive impairment caused by Alzheimer's disease leaves individuals unable to maintain gainful employment and deserving of an expedited disability determination.

"As the leading research, advocacy, and support organization for Alzheimer's disease, the Alzheimer's Association has actively sought the inclusion of early-onset Alzheimer's in the Social Security Administration's Compassionate Allowances Initiative," says Harry Johns, President and CEO of the Alzheimer's Association. "Now, individuals who are dealing with the enormous challenges of Alzheimer's won't also have to endure the financial and emotional toll of a long disability decision process."

Since 2003, the Alzheimer's Association has been advocating on behalf of individuals with early-onset Alzheimer's as they navigate the Social Security disability determinations process and welcomes the SSA's decision.  Until now, individuals with early-onset Alzheimer's disease have faced a myriad of challenges when applying for SSDI or SSI, including a long decision process, initial denials, and multiple appeals.  Today's decision will simplify and streamline the SSDI/SSI application process and decrease the wait time for benefits, which for some has lasted as long as three years.  

There are currently an estimated 5.3 million Americans with Alzheimer's disease. Although the majority of Alzheimer cases are individuals age 65 and older, a significant number of people under age 65 are also affected by this fatal disease and have few financial options other than the Social Security disability program.

In addition to Alzheimer's disease, mixed-dementia and Primary Progressive Aphasia were also added to the Compassionate Allowances Initiative under the SSA's recent decision. To determine which diseases and conditions to include, SSA has held several public outreach hearings throughout the country that have included testimony from medical and scientific experts, as well as those directly affected by these diseases and conditions. The July 2009 Compassionate Allowance Hearing on Early-Onset Alzheimer's Disease and Related Dementias, held in Chicago, included testimony from Johns, several of the nation's top Alzheimer researchers, and caregivers and individuals with early-onset Alzheimer's who discussed the challenges they faced during the disability application process. During the day-long hearing, SSA officials heard about the terminal nature of Alzheimer's, the disabilities that often prohibit work in even the earliest stages of the disease, and the lack of effective treatments to modify or halt the progression of Alzheimer's.

In addition to participation in the hearing, as many as 600 people with Alzheimer's and other dementias and their caregivers responded to the Association's request to submit written comments to SSA about their experiences applying for disability benefits. A sample of these comments are posted on SSA's Compassionate Allowances website:

The Social Security Administration's proactive efforts to "fast track" certain conditions will help to reduce the backlog of disability claims and, more importantly, ensure those claims that fall under this initiative will be decided within days instead of months or years.  

"The diagnosis of Alzheimer's indicates significant enough cognitive impairment to interfere with daily living activities, including the ability to work. This decision will help a significant number of Alzheimer families. It will also help the Social Security Administration, since long delays and appeals in the disability determination process are costly for the agency," says Johns. "The Alzheimer's Association praises SSA for this decision and remains committed to continue to work with Commissioner Astrue and his colleagues at the Social Security Administration in support of its implementation nationwide."

Alzheimer's Association

The Alzheimer's Association is the leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's. For more information, visit .

SOURCE Alzheimer's Association



SOURCE Alzheimer's Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Alzheimers Research Target May Be a Dead End
2. American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women
3. Emergency Nurses Association Announces Corporate Sponsors for Leadership Conference
4. Nurse-Attorney/Former Bristol-Myers Squibb Executive Selected To Lead New Jersey State Nurses Association
5. Highmark Foundation Awards $120,000 to the American Heart Association
6. Satellite Healthcares Sheila Doss Elected Western Chapters Coordinator-Elect of the American Nephrology Nurses Association
7. Qui Tam Attorney Tim Terry Participating in Training Event Sponsored by Puget Sound Chapter of the National Contract Management Association (NCMA)
8. Obamas Budget Proposals Will Thwart Charitable Giving to Keep Nonprofit Hospitals Operating, Association for Healthcare Philanthropy Says
9. Life Line Screening Supports the American Heart Association's 'Go Red for Women' Event in Denver, Colorado
10. Statement from the Consumer Healthcare Products Association on Mississippi Bill that Limits Consumer Access to Cold and Allergy Medicines Containing Pseudoephedrine by Requiring a Prescription
11. Cosan-Shell Deal Expands Global Penetration Outlook for Brazilian Ethanol, Says Brazilian Sugarcane Industry Association
Post Your Comments:
(Date:11/27/2015)... ... , ... ProSidebar: Fashion is a set of 30 kinetic edge ... video editors can easily add an informative sidebar to any FCPX production. Create ... featuring self-animating drop zones, lines, bars, and text with the ease of FCPX's drag ...
(Date:11/27/2015)... ... ... A simply groundbreaking television series, "Voices in America", which is hosted by Hollywood ... issues that are presently affecting Americans. Dedicated to providing the world with a wide ... subjects consumers focus on, one episode at a time. , In the latest ...
(Date:11/27/2015)... IL (PRWEB) , ... November 27, 2015 , ... ... of the largest, most successful and prominent nonprofit healthcare organizations in the country. ... governance involvement with various organizations, and helped advance the healthcare industry as a ...
(Date:11/26/2015)... ... 26, 2015 , ... Patients at Serenity Point Recovery, a ... on Thanksgiving Day to share the things that they are most grateful for ... YouTube channel, patients displayed what they wrote on index cards, describing the things ...
(Date:11/26/2015)... ... ... The Catalent Applied Drug Delivery Institute today announced a ... selection in early phase drug development. The first of these is to be ... UK’s emerging life sciences companies, corporate partners, and investors, at Milton Park, Oxford, ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 Un nuevo enfoque ... para el cáncer avanzado.   --> ... fotodinámica de Bremachlorin para el cáncer avanzado.   ... inmunoterapia con la terapia fotodinámica de Bremachlorin para el ... . --> Clinical Cancer Research . ...
(Date:11/26/2015)... -- Research and Markets ( ) has announced the ... to 2019 - Rise in Cardiac Disorders and Growing Awareness ... their offering. Boston scientific ... scientific and others. --> The market is ... Boston scientific and others. ...
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
Breaking Medicine Technology: